Abstract
Rationale
Due to the proximity of craniopharyngiomas to the hypothalamus and pituitary gland, most children and adolescents presenting with these tumors will exhibit significant endocrine dysfunction. After treatment, these impairments can become a major cause of morbidity and mortality.
Methods
The postoperative course of children undergoing surgery for craniopharyngioma is reviewed.
Conclusion
Even if hormone levels seem to be adequate in the short term after treatment, deficiencies may develop over years and need to be monitored closely.
Similar content being viewed by others
References
Chakrabarty A, Mitchell P, Bridges LR (1998) Craniopharyngioma invading the nasal and paranasal spaces, and presenting as nasal obstruction. Br J Neurosurg 12(4):361–363
Sklar CA (1994) Craniopharyngioma: endocrine abnormalities at presentation. Pediatr Neurosurg 21(Suppl 1):18–20
Robinson AG, Verbalis JG (2003) Posterior pituitary gland. In: Larsen PR, Kronenberg HM, Melmed S, Polonsky KS (eds) Williams textbook of endocrinology. Elsevier Science, Philadelphia, PA, pp 281–329
Banna M, Hoare RD, Stanley P, Till K (1973) Craniopharyngioma in children. J Pediatr 83(5):781–785
de Vries L, Lazar L, Phillip M (2003) Craniopharyngioma: presentation and endocrine sequelae in 36 children. J Pediatr Endocrinol Metab 16(5):110–703
Thomsett MJ, Conte FA, Kaplan SL, Grumbach MM (1980) Endocrine and neurologic outcome in childhood craniopharyngioma: review of effect of treatment in 42 patients. J Pediatr 97(5):728–735
Sorva R (1988) Children with craniopharyngioma. Early growth failure and rapid postoperative weight gain. Acta Paediatr Scand 77(4):587–592
Wit JM, Schuitema-Dijkstra A, van Buul-Offers S, Opmeer F, Van den Brande JL (1988) Excessive growth in a child with craniopharyngioma and growth hormone deficiency. Eur J Pediatr 147(6):658–661
Blethen SL, Weldon VV (1986) Outcome in children with normal growth following removal of a craniopharyngioma. Am J Med Sci 292(1):21–24
Weinzimer SA, Homan SA, Ferry RJ, Moshang T (1999) Serum IGF-I and IGFBP-3 concentrations do not accurately predict growth hormone deficiency in children with brain tumours. Clin Endocrinol (Oxf) 51(3):339–345
Moshang T Jr, Rundle AC, Graves DA, Nickas J, Johanson A, Meadows A (1996) Brain tumor recurrence in children treated with growth hormone: the National Cooperative Growth Study experience. J Pediatr 128(5 Pt 2):S4–S7
Wilton P, Price DA (1992) Rate of relapse of craniopharyngioma in children treated with growth hormone. KIGS Biannu Rep No 8 1:48–54
Niu DM, Guo WY, Pan HC, Wong TT (2002) Rapid enlargement of a residual craniopharyngioma during short-term growth hormone replacement. Childs Nerv Syst 18(3–4):164–165. Epub 2002 Mar 5
Matson DD (1964) Craniopharyngioma. Clin Neurosurg 10:116–129
Lustig RH, Post SR, Srivannaboon K, Rose SR, Danish RK, Burghen GA, Xiong X, Wu S, Merchant TE (2003) Risk factors for the development of obesity in children surviving brain tumors. J Clin Endocrinol Metab 88(2):611–616
Muller HL, Emser A, Faldum A, Bruhnken G, Etavard-Gorris N, Gebhardt U, Oeverink R, Kolb R, Sorensen N (2004) Longitudinal study on growth and body mass index before and after diagnosis of childhood craniopharyngioma. J Clin Endocrinol Metab 89(7):3298–3305
Attia N, Tamborlane WV, Heptulla R, Maggs D, Grozman A, Sherwin RS, Caprio S (1998) The metabolic syndrome and insulin-like growth factor I regulation in adolescent obesity. J Clin Endocrinol Metab 83(5):1467–1471
Schoenle EJ, Zapf J, Prader A, Torresani T, Werder EA, Zachmann M (1995) Replacement of growth hormone (GH) in normally growing GH-deficient patients operated for craniopharyngioma. J Clin Endocrinol Metab 80(2):374–378
Pajas M, Lucas T, Garcia-Uria J, Salame F, Barcelo B, Estrada J (1995) Hypothalamic–pituitary dysfunction in patients with craniopharyngioma. Clin Endocrinol (Oxf) 42(5):467–473
Clopper RR, Mazur T, MacGillivray MH, Peterson RE, Voorhess ML (1983) Data on virilization and erotosexual behavior in male hypogonadotropic hypopituitarism during gonadotropin and androgen treatment. J Androl 4(5):303–311
Abbaticchio G, Micale FM, Giagulli VA, Giorgino R (1985) Recovery of fertility in a hypogonadotropic man apparently resistant to gonadotrophin treatment. Arch Androl 15(1):59–64
Volz J, Heinrich U, Volz-Koster S (2002) Conception and spontaneous delivery after total hypophysectomy. Fertil Steril 77(3):624–625
Hayashi M, Tomobe K, Hoshimoto K, Ohkura T (2002) Successful pregnancy following gonadotropin therapy in a patient with hypogonadotropic hypogonadism resulting from craniopharyngioma. Int J Clin Pract 56(2):149–151
Zachmann M, Illig R (1979) Precocious puberty after surgery for craniopharyngioma. J Pediatr 95(1):86–88
Persani L, Ferretti E, Borgato S, Faglia G, Beck-Peccoz P (2000) Circulating thyrotropin bioactivity in sporadic central hypothyroidism. J Clin Endocrinol Metab 85(10):3631–3635
Gruneiro-Papendieck L, Chiesa A, Martinez A, Heinrich JJ, Bergada C (1998) Nocturnal TSH surge and TRH test response in the evaluation of thyroid axis in hypothalamic pituitary disorders in childhood. Horm Res 50(5):252–257
Bin-Abbas B, Mawlawi H, Sakati N, Khafaja Y, Chaudhary MA, Al-Ashwal A (2001) Endocrine sequelae of childhood craniopharyngioma. J Pediatr Endocrinol Metab 14(7):869–874
Isojarvi JI, Turkka J, Pakarinen AJ, Kotila M, Rattya J, Myllyla VV (2001) Thyroid function in men taking carbamazepine, oxcarbazepine, or valproate for epilepsy. Epilepsia 42(7):930–934
Surks MI, DeFesi CR (1996) Normal serum free thyroid hormone concentrations in patients treated with phenytoin or carbamazepine. A paradox resolved. JAMA 275(19):1495–1498
Lyen KR, Grant DB (1982) Endocrine function, morbidity, and mortality after surgery for craniopharyngioma. Arch Dis Child 57(11):837–841
Rose SR, Danish RK, Kearney NS, Schreiber RE, Lustig RH, Burghen GA, Hudson MM (2005) ACTH deficiency in childhood cancer survivors. Pediatr Blood Cancer, Feb 7
Styne DM, Richards GE, Bell JJ et al (1977) Growth patterns in congenital adrenal hyperplasia: correlation of glucocorticoid therapy with stature. In: Lee P, Plotnick L, Kowarski A, Migeon C (eds) Congenital adrenal hyperplasia. University Park Press, Baltimore, pp 247–261
Linder BL, Esteban NV, Yergey AL, Winterer JC, Loriaux DL, Cassorla F (1990) Cortisol production rate in childhood and adolescence. J Pediatr 117(6):892–896
Kerrigan JR, Veldhuis JD, Leyo SA, Iranmanesh A, Rogol AD (1993) Estimation of daily cortisol production and clearance rates in normal pubertal males by deconvolution analysis. J Clin Endocrinol Metab 76(6):1505–1510
Miller WL (2003) The adrenal cortex. In: Sperling MA (ed) Pediatric endocrinology. Elsevier Science, Philadelphia, PA pp 385–438
Lehrnbecher T, Muller-Scholden J, Danhauser-Leistner I, Sorensen N, von Stockhausen HB (1998) Perioperative fluid and electrolyte management in children undergoing surgery for craniopharyngioma. A 10-year experience in a single institution. Childs Nerv Syst 14(6):276–279
Gonzales-Portillo G, Tomita T (1998) The syndrome of inappropriate secretion of antidiuretic hormone: an unusual presentation for childhood craniopharyngioma: report of three cases. Neurosurgery 42(4):917–921; discussion 921–922
Hetelekidis S, Barnes PD, Tao ML, Fischer EG, Schneider L, Scott RM, Tarbell NJ (1993) 20-year experience in childhood craniopharyngioma. Int J Radiat Oncol Biol Phys 27(2):189–195
Jeanrenaud B (1985) An hypothesis on the aetiology of obesity: dysfunction of the central nervous system as a primary cause. Diabetologia 28(8):502–513 Review
Bray GA, York DA (1979) Hypothalamic and genetic obesity in experimental animals: an autonomic and endocrine hypothesis. Physiol Rev 59(3):719–809
Smith DK, Sarfeh J, Howard L (1983) Truncal vagotomy in hypothalamic obesity. Lancet 1(8337):1330–1331
Lustig RH, Rose SR, Burghen GA, Velasquez-Mieyer P, Broome DC, Smith K, Li H, Hudson MM, Heideman RL, Kun LE (1999) Hypothalamic obesity caused by cranial insult in children: altered glucose and insulin dynamics and reversal by a somatostatin agonist. J Pediatr 135(2 Pt 1):162–168
Mason PW, Krawiecki N, Meacham LR (2002) The use of dextroamphetamine to treat obesity and hyperphagia in children treated for craniopharyngioma. Arch Pediatr Adolesc Med 156(9):887–892
Larijani B, Bastanhagh MH, Pajouhi M, Kargar Shadab F, Vasigh A, Aghakhani S (2004) Presentation and outcome of 93 cases of craniopharyngioma. Eur J Cancer Care (Engl) 13(1):11–15
Sorva R, Heiskanen O, Perheentupa J (1988) Craniopharyngioma surgery in children: endocrine and visual outcome. Childs Nerv Syst 4(2):97–99
Nakasu Y, Nakasu S, Handa J, Takeuchi J (1980) Amenorrhea–galactorrhea syndrome with craniopharyngioma. Surg Neurol 13(2):154–156
Muller HL, Handwerker G, Wollny B, Faldum A, Sorensen N (2002) Melatonin secretion and increased daytime sleepiness in childhood craniopharyngioma patients. J Clin Endocrinol Metab 87(8):3993–3996
Tomlinson JW, Holden N, Hills RK, Wheatley K, Clayton RN, Bates AS, Sheppard MC, Stewart PM (2001) Association between premature mortality and hypopituitarism. West midlands prospective hypopituitary study group. Lancet 357(9254):425–431
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Halac, I., Zimmerman, D. Endocrine manifestations of craniopharyngioma. Childs Nerv Syst 21, 640–648 (2005). https://doi.org/10.1007/s00381-005-1246-x
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00381-005-1246-x